<DOC>
	<DOCNO>NCT00190281</DOCNO>
	<brief_summary>To evaluate change microcirculation liver , kidney spleen acute infection patient malaria ( cohort 1 3 ) infectious disease acute pyelonephritis day 0 ( within 8 hour treatment start ) , day 2 4 day 28-32 , use functional US continuous infusion contrast agent ( SonoVue , Bracco , Italy ) . Study hypothesis : malaria patient exhibit different pattern enhancement , particularly quantitative measurement SU signal perform destruction reperfusion kinetics .</brief_summary>
	<brief_title>Contrast-Enhanced US Spleen , Liver Kidney</brief_title>
	<detailed_description>To evaluate change microcirculation liver , kidney spleen acute infection patient malaria ( cohort 1 3 ) infectious disease acute pyelonephritis day 0 ( within 8 hour treatment start ) , day 2 4 day 28-32 , use functional US continuous infusion contrast agent ( SonoVue , Bracco , Italy ) . Three cohortes study : cohorte 1 infection Plasmodium falciparum ( 24 patient ) , cohorte 3 infection Plasmodium vivax , ovale malariae ( 5 patient ) cohorte 2 infectious disease acute pyelonephritis ( 24 patient ) . Study hypothesis : malaria patient exhibit different pattern enhancement , particularly quantitative measurement SU signal perform destruction reperfusion kinetics .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Pyelonephritis</mesh_term>
	<criteria>Social security number Age 18 acute malaria infection infectious disease Inpatients Signed informed consent form Pregnancy Criteria bad tolerance infection Treatment start 8 hour Lack cooperation History splenectomy , hematological disease , cirrhosis portal hypertension , splenomegaly Medical treatment beta blocker , diuretic , immunodepression drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2005</verification_date>
	<keyword>FUNCTIONAL STUDY</keyword>
	<keyword>CONTRAST-ENHANCED US</keyword>
	<keyword>PERFUSION</keyword>
</DOC>